2021 Annual Meeting | C90 - Introduction to Primary Headache Disorders: Migraine and Other Primary Headaches, Including Tension-type, Hypnic, Primary Stabbing, Nummular Headache Syndromes, Epicrania Fugax, and Retinal Migraine

Date Wednesday 04/21/21

Time 06:00 PM - 07:00 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Hope M. O'Brien, MD, MBA, FAAN

Moderator(s) Andrew J. Westwood, MD, FAAN

Topic(s) Headache

Learning Objectives Participants should become familiar on how to diagnosis and distinguish between various primary headache disorders and define various types based on the the International Classification of Headache Disorders, 3rd edition.

CME Available 1.00 CME credit

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice

Program Level Introductory

Program Tracks Advanced Practice Provider

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student

Teaching Styles Case-based, Didactic

Program Materials Program Evaluations

Event Timeline
06:00 PM - 06:05 PM EDT	Introduction	Introduction Hope M. O'Brien, MD, MBA, FAAN
06:05 PM - 06:25 PM EDT	Speaker	Migraine and Primary Headache Disorders Hope M. O'Brien, MD, MBA, FAAN
06:25 PM - 06:50 PM EDT	Speaker	Tension-type, Hypnic, Primary Stabbing, Nummular Headache Syndromes, Epicrania Fugax, and Retinal Migraine Joanne Kacperski, MD
06:50 PM - 07:00 PM EDT	Q&A	Live Q&A Hope M. O'Brien, MD, MBA, FAAN, Joanne Kacperski, MD

Faculty Disclosures
Hope M. O'Brien, MD, MBA, FAAN	The institution of Dr. O'Brien has received personal compensation in the range of $0-$499 for serving as a Consultant for Guidepoint. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. The institution of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving as a Consultant for AbbVie. An immediate family member of Dr. O'Brien has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zenica. The institution of Dr. O'Brien has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. O'Brien has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Eli Lilly. The institution of Dr. O'Brien has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Scilex. The institution of Dr. O'Brien has received research support from Abbvie. The institution of Dr. O'Brien has received research support from Eli Lilly. Dr. O'Brien has received publishing royalties from a publication relating to health care. Dr. O'Brien has a non-compensated relationship as a Accreditation Council Member with UCNS that is relevant to AAN interests or activities.
Joanne Kacperski, MD	Dr. Kacperski has nothing to disclose.
Andrew J. Westwood, MD, FAAN	Dr. Westwood has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Healthcare Business Solutions UK.

��ɫ��

��ɫ��